Hiywot MS's Colleagues at QED Therapeutics
Sam Casillas
Head of KOL Advocacy Development, Oncology/Rare Disease Marketing & Commercialization
Hiywot MS's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Hiywot MS's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Hiywot MS
Hiywot MS currently works for QED Therapeutics.
Hiywot MS's role at QED Therapeutics is Director Clinical Operations.
Hiywot MS's email address is ***@qedtx.com. To view Hiywot MS's full email address, please signup to ConnectPlex.
Hiywot MS works in the Biotechnology industry.
Hiywot MS's colleagues at QED Therapeutics are Devendra A., Timothy Bisson, Quinn Nazarewycz, Jennifer Lai, Shivani Pandit, Chelsea Guiseppi, Sam Casillas and others.
Hiywot MS's phone number is 650-231-4088